sinc
surgic
pathologist
gener
infecti
diseas
pathologist
particular
dealt
increas
number
surgic
specimen
patient
one
multipl
infecti
agent
may
respons
diseas
context
pathologist
play
import
role
recogn
infecti
agent
mani
case
fresh
tissu
avail
cultur
pathologist
provid
rapid
morpholog
diagnosi
facilit
clinic
decis
patient
treatment
addit
pathologist
play
central
role
identif
emerg
reemerg
infecti
agent
describ
pathogenet
process
emerg
diseas
hantaviru
pulmonari
syndrom
viral
hemorrhag
fever
leptospirosi
rickettsi
ehrlichi
infect
well
diagnosi
anthrax
bioterrorist
attack
convent
microbi
identif
infecti
diseas
made
primarili
use
serolog
assay
cultur
techniqu
howev
serolog
result
difficult
interpret
set
immunosuppress
singl
sampl
avail
evalu
addit
fresh
tissu
alway
avail
cultur
cultur
fastidi
pathogen
difficult
may
take
week
month
yield
result
moreov
cultur
alon
distinguish
colon
tissu
invas
microorgan
distinct
morpholog
characterist
allow
identif
formalinfix
tissu
use
routin
special
stain
nevertheless
sever
instanc
difficult
even
imposs
identifi
infecti
agent
specif
convent
morpholog
method
immunohistochemistri
one
power
techniqu
surgic
patholog
increas
interest
use
specif
antibodi
viral
bacteri
fungal
parasit
antigen
detect
identif
caus
agent
mani
infecti
diseas
use
specif
antibodi
detect
microbi
antigen
first
perform
coon
associ
detect
pneumococc
antigen
tissu
advantag
immunohistochemistri
convent
stain
method
tabl
contribut
immunohistochemistri
infecti
diseas
tabl
substanti
import
emphas
monoclon
polyclon
antibodi
must
test
possibl
crossreact
organ
widespread
occurr
common
antigen
among
bacteria
pathogen
fungi
well
establish
final
import
understand
immunohistochemistri
sever
step
affect
final
result
howev
gener
limit
avail
specif
antibodi
preserv
epitop
well
known
larger
microorgan
protozoa
fungi
bacteria
pretreat
formalinfix
paraffinembed
tissu
requir
contrast
smaller
infecti
agent
exampl
microorgan
virus
chlamydia
pretreat
tissu
proteolyt
enzym
heatinduc
epitop
retriev
necessari
order
enhanc
immunoreact
perform
formalinfix
paraffinembed
tissu
reduc
risk
exposur
seriou
infecti
diseas
high
sensit
allow
identif
infecti
agent
even
morpholog
chang
occur
use
retrospect
diagnosi
individu
patient
indepth
studi
diseas
specif
monoclon
antibodi
polyclon
antibodi
allow
specif
identif
infecti
agent
immunohistochemistri
play
import
role
diagnosi
larg
number
viral
infect
also
studi
pathogenesi
epidemiolog
tradit
diagnosi
viral
infect
reli
cytopath
chang
observ
routin
histopatholog
sever
viral
pathogen
produc
characterist
intracellular
inclus
allow
pathologist
make
presumpt
diagnosi
viral
infect
howev
viral
infect
characterist
cytopath
chang
often
subtl
spars
requir
meticul
search
moreov
known
viral
diseas
associ
characterist
intracellular
inclus
addit
formalin
commonli
use
fix
histopatholog
poor
fix
demonstr
morpholog
tinctori
featur
viral
inclus
viral
inclus
detect
hematoxylineosin
stain
section
viral
inclus
present
differenti
viral
diseas
immunohistochem
techniqu
offer
reliabl
altern
reach
specif
diagnosi
hepat
b
viru
infect
constitut
import
caus
chronic
hepat
signific
proport
patient
mani
instanc
morpholog
chang
induc
hepat
b
viru
hepatocyt
typic
enough
render
presumpt
diagnosi
hepat
b
viral
infect
instanc
may
littl
hepat
b
surfac
antigen
hbsag
demonstr
techniqu
orcein
stain
case
immunohistochem
techniqu
detect
hbsag
sensit
histochem
method
help
reach
diagnosi
immunostain
hbsag
use
diagnosi
hepat
b
studi
carrier
state
eighti
percent
case
posit
serolog
result
hbsag
demonstr
cytoplasm
hbsag
use
immunohistochemistri
fig
immunoperoxidas
local
hepat
b
core
antigen
hbcag
demonstr
within
nuclei
cytoplasm
hepatocyt
fig
predominantli
cytoplasm
express
hbcag
associ
higher
grade
hepat
activ
clinic
diagnosi
hepat
c
viru
hcv
infect
base
serolog
demonstr
antibodi
hcv
detect
hcv
rna
serum
howev
antihcv
antibodi
may
detect
sera
immunocompromis
patient
sever
polyclon
monoclon
antibodi
direct
hcv
recent
monoclon
antibodi
hcv
envelop
glycoprotein
demonstr
highli
sensit
antibodi
diagnosi
clinic
followup
chronic
hcv
hepat
overal
accuraci
use
envis
techniqu
antibodi
use
earli
detect
graft
reinfect
patient
liver
transplant
hcvrelat
cirrhosi
differenti
reinfect
graft
reject
histolog
diagnosi
herp
simplex
viru
hsv
infect
involv
detect
multinucl
giant
cell
contain
characterist
mold
ground
glassappear
nuclei
cowdri
type
intranuclear
inclus
abund
viral
inclus
within
infect
cell
diagnosi
usual
straightforward
howev
diagnosi
hsv
infect
difficult
characterist
intranuclear
inclus
multinucl
cell
absent
amount
tissu
biopsi
specimen
small
case
use
immunohistochemistri
detect
hsv
antigen
advantag
immunohistochemistri
use
either
polyclon
monoclon
antibodi
hsv
antigen
proven
sensit
specif
techniqu
diagnos
hsv
infect
fig
although
polyclon
antibodi
major
hsv
glycoprotein
antigen
sensit
allow
distinct
two
virus
antigen
similar
addit
histolog
featur
hsv
infect
specif
also
occur
patient
varicellazost
vzv
infect
monoclon
antibodi
vzv
envelop
glycoprotein
suffici
sensit
specif
allow
clearcut
distinct
hsv
vzv
infect
immunohistochemistri
also
use
demonstr
associ
human
herpesviru
kaposi
sarcoma
primari
effus
lymphoma
multicentr
castleman
diseas
diagnosi
kaposi
sarcoma
may
problemat
due
broad
morpholog
spectrum
similar
appear
benign
malign
neoplast
vascular
lesion
immunostain
kaposi
sarcoma
latent
associ
nuclear
use
confirm
diagnosi
kaposi
sarcoma
particularli
difficult
earli
lesion
neoplasm
present
unusu
locat
allow
distinct
kaposi
sarcoma
sever
morpholog
similar
vasoprolif
lesion
see
chapter
immunostain
restrict
nuclei
spindl
cell
endotheli
cell
slitlik
vascular
space
immunohistochemistri
also
demonstr
express
mesotheli
cell
hivassoci
recurr
pleural
effus
cell
plexiform
lesion
primari
pulmonari
hypertens
cytomegaloviru
cmv
import
opportunist
pathogen
immunocompromis
patient
histolog
diagnosi
cmv
fix
tissu
usual
rest
identif
characterist
cytopath
effect
includ
intranuclear
cytoplasm
inclus
howev
histolog
examin
lack
sensit
case
atyp
cytopath
featur
confus
reactiv
degen
chang
case
immunohistochemistri
use
monoclon
antibodi
earli
late
cmv
antigen
allow
detect
cmv
antigen
nucleu
cytoplasm
infect
cell
fig
addit
immunohistochemistri
may
allow
detect
cmv
antigen
earli
cours
diseas
cytopath
chang
yet
develop
exampl
cmv
earli
nuclear
antigen
express
hour
cellular
infect
indic
earli
activ
viral
replic
immunohistochemistri
use
detect
cmv
infect
patient
steroid
refractori
ulcer
coliti
detect
occult
cmv
infect
central
nervou
system
liver
transplant
patient
develop
neurolog
complic
also
use
demonstr
high
frequenc
cmv
antigen
tissu
first
trimest
abort
sensit
immunohistochemistri
better
light
microscop
identif
viral
inclus
compar
favor
cultur
situ
hybrid
addit
immunohistochem
assay
complet
faster
shell
vial
techniqu
immunofluoresc
cultur
allow
rapid
result
import
earli
anticmv
therapi
adenoviru
increasingli
recogn
caus
morbid
mortal
among
immunocompromis
patient
owe
transplant
congenit
immunodefici
rare
adenoviru
infect
describ
hivinfect
patient
characterist
adenoviru
inclus
amphophil
intranuclear
homogen
glassi
howev
case
infect
may
contain
rare
cell
show
characterist
cytopath
effect
addit
viral
inclus
includ
cmv
human
papillomaviru
hsv
vzv
mistaken
adenoviru
inclus
vice
versa
moreov
immunosuppress
patient
incid
coinfect
virus
high
circumst
immunohistochem
assay
may
necessari
definit
diagnosi
monoclon
antibodi
reactiv
serotyp
adenoviru
use
immunohistochem
techniqu
demonstr
intranuclear
adenovir
antigen
immunocompromis
patient
fig
histolog
diagnosi
adenoviru
coliti
difficult
usual
underdiagnos
immunohistochem
stain
valu
differenti
adenoviru
coliti
cmv
coliti
herpesvirus
infect
diagnos
use
immunohistochem
method
includ
epsteinbarr
viral
infect
human
herpesvirusu
infect
parvoviru
associ
asymptomat
infect
erythema
infectiosum
acut
arthropathi
aplast
crisi
hydrop
fetali
chronic
anemia
red
cell
aplasia
diagnosi
parvoviru
infect
achiev
identifi
typic
find
bone
marrow
specimen
includ
decreas
absent
red
cell
precursor
giant
pronormoblast
eosinophil
amphophil
intranuclear
inclus
erythroid
cell
intraven
immunoglobulin
therapi
effect
rapid
accur
diagnost
method
import
immunohistochemistri
monoclon
antibodi
capsid
protein
use
rapid
sensit
method
establish
diagnosi
parvoviru
infect
formalinfix
paraffinembed
tissu
immunohistochemistri
particular
help
detect
parvoviru
antigen
case
spars
inclus
studi
case
initi
identifi
examin
routin
stain
tissu
section
case
hydrop
fetali
advanc
cytolysi
fig
sever
studi
found
good
correl
morpholog
immunohistochem
situ
hybrid
polymeras
chain
reaction
pcr
sinc
numer
emerg
reemerg
agent
viral
hemorrhag
fever
attract
attent
pathologist
investig
play
import
role
identif
agent
support
epidemiolog
clinic
pathogenet
studi
emerg
viral
hemorrhag
fever
viral
hemorrhag
fever
often
fatal
absenc
bleed
organ
manifest
diseas
clinic
difficult
diagnos
frequent
requir
handl
test
potenti
danger
biolog
specimen
addit
histopatholog
featur
pathognomon
resembl
viral
rickettsi
bacteri
eg
leptospirosi
infect
immunohistochemistri
essenti
success
safe
appli
diagnosi
studi
pathogenesi
diseas
sever
studi
establish
util
immunohistochemistri
sensit
safe
rapid
diagnost
method
diagnosi
viral
hemorrhag
fever
yellow
fever
fig
dengu
hemorrhag
fever
crimeancongo
hemorrhag
fever
argentin
hemorrhag
fever
venezuelan
hemorrhag
fever
marburg
diseas
addit
sensit
specif
safe
immunostain
method
develop
diagnos
ebola
hemorrhag
fever
formalinfix
skin
biopsi
fig
immunohistochemistri
demonstr
lassa
viru
target
primarili
endotheli
cell
mononuclear
inflammatori
cell
hepatocyt
fig
immunohistochemistri
detect
human
papillomaviru
formalinfix
tissu
replac
sensit
diagnost
molecular
techniqu
situ
hybrid
addit
low
sensit
compar
molecular
techniqu
immunohistochemistri
detect
product
latent
infect
use
determin
type
viru
present
fig
bk
viru
infect
frequent
infanc
immunocompet
individu
viru
remain
latent
kidney
central
nervou
system
blymphocyt
immunocompromis
patient
infect
reactiv
spread
organ
kidney
infect
associ
mononuclear
interstiti
inflammatori
infiltr
tubular
atrophi
find
difficult
distinguish
acut
transplant
reject
besid
cytopath
chang
observ
bk
viru
infect
pathognomon
observ
viral
infect
set
immunohistochemistri
use
demonstr
bk
viru
infect
human
polyomaviru
jc
doublestrand
dna
viru
caus
progress
multifoc
leukoencephalopathi
pml
fatal
demyelin
diseas
character
cytopath
chang
oligodendrocyt
bizarr
giant
astrocyt
immunohistochem
techniqu
use
polyclon
rabbit
antiserum
protein
specif
sensit
rapid
method
confirm
diagnosi
pml
jc
viru
antigen
usual
seen
within
oligodendrocyt
occasion
astrocyt
antigenbear
cell
commonli
seen
earli
lesion
immunohistochemistri
also
use
confirm
diagnosi
respiratori
viral
diseas
influenza
viru
respiratori
syncyti
viru
infect
cultur
avail
diagnosi
rabi
reli
heavili
histopatholog
examin
tissu
demonstr
characterist
cytoplasm
inclus
negri
bodi
import
percentag
case
negri
bodi
may
inconspicu
confirm
diagnosi
rabi
may
extrem
difficult
furthermor
nonendem
area
diagnosi
rabi
usual
suspect
clinic
patient
present
ascend
type
paralysi
set
immunohistochem
stain
sensit
safe
specif
diagnost
tool
rabi
fig
viral
agent
diagnos
use
immunohistochem
method
includ
enteroviru
eastern
equin
enceph
rotaviru
among
bacteri
infect
greatest
number
immunohistochem
studi
perform
investig
helicobact
pylori
studi
evalu
use
immunohistochemistri
bacteri
mycobacteri
rickettsi
spirochet
infect
antigen
retriev
gener
requir
immunohistochem
demonstr
bacteria
fix
tissu
howev
interpret
result
complic
fact
mani
antibodi
crossreact
bacteria
moreov
antibodi
may
react
portion
bacteria
may
label
remnant
bacteria
spirochet
viabl
organ
longer
present
gastric
infect
h
pylori
result
chronic
activ
gastriti
strongli
associ
lymphoid
hyperplasia
gastric
lymphoma
gastric
adenocarcinoma
heavi
infect
numer
organ
easili
detect
routin
hematoxylin
eosinstain
tissu
howev
detect
rate
mani
falseposit
falseneg
result
convent
histochem
method
silver
stain
sensit
hematoxylin
eosin
detect
h
pylori
nonetheless
detect
scant
number
organ
immunohistochemistri
prove
highli
specif
sensit
less
expens
factor
consid
superior
convent
histochem
method
fig
treatment
chronic
activ
gastriti
h
pylori
infect
chang
shape
microorgan
make
difficult
identif
differenti
extracellular
debri
mucin
globul
case
immunohistochemistri
improv
rate
success
whippl
diseas
affect
primarili
small
bowel
mesenter
lymph
node
less
commonli
organ
heart
central
nervou
system
numer
foami
macrophag
character
diseas
diagnosi
usual
reli
demonstr
pasposit
intracytoplasm
bacteria
nevertheless
presenc
pasposit
macrophag
pathognomon
observ
diseas
mycobacterium
avium
complex
infect
histoplasmosi
infect
due
rhodococcu
equi
macroglobulinemia
immunohistochem
stain
rabbit
polyclon
antibodi
provid
sensit
specif
method
rapid
diagnosi
intestin
extraintestin
whippl
diseas
followup
treatment
respons
confirm
rocki
mountain
spot
fever
rmsf
usual
requir
use
serolog
method
detect
antibodi
spot
fever
group
sfg
rickettsia
yet
signific
percentag
patient
rmsf
lack
diagnost
titer
first
week
diseas
immunohistochemistri
success
use
detect
sfg
rickettsia
formalinfix
tissu
section
fig
sever
studi
illustr
valu
immunohistochemistri
diagnosi
suspect
case
rmsf
use
skin
biopsi
confirm
fatal
case
seroneg
rmsf
bartonella
slow
grow
fastidi
gramneg
warthinstarrystain
bacteria
associ
bacillari
angiomatosi
peliosi
hepati
catscratch
diseas
blood
cultureneg
endocard
immunostain
success
use
identifi
bartonella
hensela
b
quintana
heart
valv
patient
blood
cultureneg
endocard
fig
polyclon
rabbit
antibodi
allow
differenti
b
hensela
b
quintana
also
use
detect
microorgan
catscratch
diseas
bacillari
angiomatosi
peliosi
hepati
commerci
avail
monoclon
antibodi
specif
b
hensela
also
avail
use
demonstr
organ
case
spontan
splenic
ruptur
caus
bacterium
bacteri
diseas
identifi
immunohistochemistri
formalinfix
tissu
includ
leptospirosi
zoonosi
usual
present
acut
febril
syndrom
occasion
unusu
manifest
pulmonari
hemorrhag
respiratori
failur
abdomin
pain
rabbit
polyclon
antibodi
use
immunohistochemistri
detect
leptospir
antigen
gallbladd
lung
patient
unusu
present
fig
lyme
diseas
protean
clinic
manifest
borrelia
burgdoferi
difficult
cultur
tissu
fluid
addit
cultur
rare
posit
week
incub
borrelia
burgdoferi
identifi
tissu
immunostain
polyclon
monoclon
antibodi
although
immunohistochemistri
specif
silver
impregn
stain
sensit
immunostain
poor
microorgan
difficult
detect
due
low
number
present
tissu
section
immunohistochemistri
use
identifi
haemophilu
influenza
chlamydia
speci
legionella
pneumophila
l
dumoffii
listeria
monocytogen
salmonella
mycobacteria
rickettsi
infect
rocki
mountain
spot
fever
boutonneus
fever
typhu
fever
rickettsialpox
african
tick
bite
fever
scrub
typhu
spirochet
patient
syphili
great
major
fungi
readili
identifi
hematoxylin
eosin
stain
alon
combin
histochem
stain
period
acidschiff
pa
gomori
methenamin
silver
gm
howev
stain
distinguish
morpholog
similar
fungi
potenti
differ
suscept
antimycot
drug
addit
fungal
element
may
appear
atyp
tissu
section
sever
factor
includ
steric
orient
age
fungal
lesion
effect
antifung
chemotherapi
type
infect
tissu
host
immun
respons
current
final
identif
fungi
reli
cultur
techniqu
howev
cultur
may
take
sever
day
longer
yield
definit
result
often
surgic
pathologist
access
fresh
tissu
past
year
immunohistochemistri
use
identifi
variou
fungal
element
paraffinembed
formalinfix
tissu
immunohistochem
method
advantag
provid
rapid
specif
identif
sever
fungi
allow
pathologist
abl
identifi
unusu
filament
hyphal
yeast
infect
accur
distinguish
confound
artifact
addit
immunohistochemistri
allow
pathologist
correl
microbiolog
histolog
find
fungal
infect
distinguish
harmless
colon
immunohistochemistri
also
help
one
fungu
present
case
dual
immunostain
techniqu
highlight
differ
fungal
speci
present
tissu
import
limit
immunohistochemistri
identif
fungi
wellknown
widespread
occurr
common
antigen
among
pathogen
fungi
frequent
result
crossreact
polyclon
antibodi
even
monoclon
antibodi
therefor
assess
crossreact
use
panel
fungi
import
step
evalu
immunohistochem
method
candida
speci
often
stain
weakli
hematoxylin
eosin
sometim
yeast
form
may
difficult
differenti
histoplasma
capsulatum
cryptococcu
neoforman
even
pneumocysti
carinii
polyclon
monoclon
antibodi
candida
genu
antigen
sensit
strongli
reactiv
show
crossreact
fungi
test
particular
two
monoclon
antibodi
candida
albican
mannoprotein
show
high
sensit
specif
monoclon
antibodi
recogn
primarili
filament
form
c
albican
wherea
monoclon
antibodi
highlight
yeast
form
identif
cryptococcu
neoforman
usual
problem
fungu
produc
mucicarmineposit
capsul
howev
infect
capsuleneg
strain
difficult
diagnos
diseas
confus
histoplasmosi
blastomycosi
torulopsi
also
longstand
infect
yeast
often
appear
atyp
fragment
polyclon
antibodi
rais
c
neoforman
yeast
cell
sensit
specif
recent
monoclon
antibodi
produc
allow
identif
differenti
varieti
c
neoforman
formalinfix
tissu
antibodi
highli
sensit
specif
differenti
c
neoforman
var
neoforman
c
neoforman
var
gattii
sporothrix
schenckii
may
confus
tissu
section
blastomyc
dermatitidi
fungal
agent
pheohyphomycosi
addit
yeast
cell
schenckii
may
spars
present
tissu
specif
antibodi
yeast
cell
schenckii
sensit
demonstr
crossreact
candida
speci
howev
specif
adsorpt
antibodi
candida
yeast
cell
crossreact
antibodi
elimin
invas
aspergillosi
frequent
caus
fungal
infect
high
morbid
mortal
rate
immunocompromis
patient
diagnosi
often
difficult
reli
heavili
histolog
identif
invas
septat
hypha
cultur
confirm
nevertheless
sever
filament
fungi
fusarium
speci
pseudallescheria
boydii
scedosporium
speci
share
similar
morpholog
aspergillu
speci
hematoxylin
eosinstain
tissu
addit
yield
cultur
histolog
proven
case
low
rang
sever
polyclon
monoclon
antibodi
aspergillu
antigen
test
formalinfix
tissu
variabl
sensit
crossreact
fungi
recent
monoclon
antibodi
aspergillu
galactomannan
shown
high
sensit
specif
identifi
fumigatu
flavu
niger
formalinfix
tissu
without
crossreact
filament
fungi
cyst
trophozoit
pneumocysti
carinii
detect
bronchoalveolar
lavag
specimen
use
monoclon
antibodi
yield
result
slightli
sensit
gm
giemsa
papanicola
stain
detect
cyst
fig
antibodi
help
diagnosi
p
carinii
pneumonia
pcp
atyp
patholog
featur
present
granulomat
pcp
presenc
hyalin
membran
case
extrapulmonari
pneumocystosi
penicillium
marneffei
usual
caus
dissemin
infect
immunocompromis
patient
clinic
resembl
histoplasmosi
leishmaniasi
morpholog
organ
must
differenti
h
capsulatum
c
neoforman
c
albican
monoclon
antibodi
galactomannan
aspergillu
speci
crossreact
detect
p
marneffei
tissu
section
immunohistochemistri
also
use
detect
blastomyc
coccidioid
histoplasma
howev
antibodi
signific
crossreact
sever
fungi
protozoa
usual
identifi
tissu
section
stain
hematoxylin
eosin
giemsa
stain
howev
small
size
organ
subtl
distinguish
featur
unequivoc
diagnosi
alway
made
role
immunohistochemistri
detect
protozo
infect
limit
case
morpholog
parasit
distort
tissu
necrosi
autolysi
addit
immunocompromis
patient
toxoplasmosi
unusu
dissemin
present
numer
tachyzoit
without
bradyzoit
fig
immunohistochemistri
also
use
case
unusu
present
diseas
diagnosi
leishmaniasi
routin
practic
usual
difficult
howev
certain
circumst
patholog
diagnosi
may
problemat
case
chronic
granulomat
leishmaniasi
small
number
parasit
microorgan
present
unusu
locat
necrosi
distort
morpholog
appear
diseas
case
immunohistochem
stain
valuabl
diagnost
tool
highli
sensit
specif
monoclon
antibodi
recogn
differ
speci
leishmania
allow
differenti
morpholog
similar
microorgan
toxoplasma
trypanosoma
cruzi
p
marneffei
immunohistochemistri
also
use
identifi
cryptosporidium
entamoeba
histolytica
trypanosoma
cruzi
babesia
giardia
lamblia
formalinfix
paraffinembed
tissu
sampl
institut
medicin
defin
emerg
infecti
diseas
eid
caus
new
previous
unidentifi
microorgan
whose
incid
human
increas
within
past
two
decad
threaten
increas
near
futur
list
pathogen
newli
recogn
sinc
long
continu
increas
recogn
emerg
infect
challeng
mani
new
infecti
agent
remain
undetect
year
emerg
identifi
public
health
problem
eid
global
phenomena
requir
global
respons
center
diseas
control
cdc
defin
strategi
prevent
detect
eid
anatom
patholog
laboratori
play
critic
role
initi
rapid
detect
eid
immunohistochemistri
besid
assist
identif
new
infecti
agent
contribut
understand
pathogenesi
epidemiolog
eid
sever
previous
healthi
individu
die
rapidli
progress
pulmonari
edema
respiratori
insuffici
shock
southwestern
unit
state
immunohistochemistri
central
identif
viral
antigen
previous
unknown
hantaviru
immunohistochem
analysi
also
import
identifi
occurr
unrecogn
case
hantaviru
pulmonari
syndrom
prior
show
distribut
viral
antigen
endotheli
cell
microcircul
particularli
lung
fig
west
nile
viru
wnv
origin
identifi
africa
first
case
wnv
enceph
us
describ
clinic
pictur
variabl
nonspecif
rang
subclin
flaccid
paralysi
enceph
character
morpholog
perivascular
mononuclear
cell
inflammatori
infiltr
neuron
necrosi
edema
microgli
nodul
particularli
promin
brainstem
cerebellum
spinal
cord
diagnosi
wnv
usual
establish
identif
virusspecif
igm
csf
andor
serum
demonstr
viral
rna
serum
csf
tissu
immunostain
either
monoclon
polyclon
antibodi
success
employ
diagnos
wnv
infect
immunocompromis
patient
lack
adequ
antibodi
respons
fig
enteroviru
associ
hand
foot
mouth
diseas
herpangina
asept
mening
poliomyelitislik
flaccid
paralysi
recent
associ
unusu
case
fulmin
enceph
pulmonari
edema
hemorrhag
heart
failur
sever
extens
encephalomyel
cerebr
cortex
brainstem
spinal
cord
describ
immunohistochem
stain
monoclon
antibodi
play
pivot
role
link
infect
fulmin
enceph
fig
viral
antigen
observ
within
neuron
neuron
process
mononuclear
inflammatori
cell
nipah
viru
recent
describ
paramyxoviru
caus
acut
febril
encephalit
syndrom
high
mortal
rate
patholog
play
key
role
identifi
caus
agent
histopatholog
find
includ
vascul
thrombosi
microinfarct
syncyti
giant
cell
viral
inclus
syncyti
giant
endotheli
cell
albeit
characterist
diseas
seen
case
viral
inclus
similar
morpholog
seen
paramyxovir
infect
immunostain
provid
use
tool
unequivoc
diagnosi
diseas
demonstr
viral
antigen
within
neuron
endotheli
cell
organ
fig
ehrlichios
bacteria
belong
genera
ehrlichia
anaplasma
agent
human
monocytotrop
ehrlichiosi
human
granulocytotrop
anaplasmosi
respect
acut
febril
ill
usual
present
cytopenia
myalgia
mild
moder
hepat
diagnosi
ehrlichiosi
depend
upon
find
characterist
monocyt
andor
granulocyt
cytoplasm
inclus
morula
pcr
analysi
blood
detect
specif
antibodi
blood
howev
morula
rare
often
miss
initi
evalu
hematoxylin
eosinstain
section
often
fail
show
organ
even
immunohistochemistri
reveal
abund
ehrlichi
antigen
antibodi
titer
may
take
sever
week
rise
diagnost
level
addit
immunocompromis
patient
may
develop
antiehrlichi
antibodi
prior
death
case
immunostain
ehrlichia
anaplasma
demonstr
sensit
specif
diagnost
method
immunohistochemistri
valuabl
approach
identif
studi
sever
eid
ebola
hemorrhag
fever
hendra
viru
enceph
leptospirosi
case
two
dozen
countri
asia
europ
north
america
south
america
earli
investig
clinic
patholog
laboratori
studi
focus
previous
known
agent
respiratori
ill
subsequ
viru
isol
oropharynx
sar
patient
identifi
ultrastructur
characterist
belong
famili
coronavirida
variou
report
describ
diffus
alveolar
damag
main
histopatholog
find
sar
patient
sarsassoci
coronaviru
sarscov
demonstr
human
experiment
anim
tissu
immunohistochem
fig
situ
hybrid
ish
assay
current
increas
concern
use
infecti
agent
potenti
biolog
weapon
biolog
warfar
agent
vari
rare
exot
virus
common
bacteri
agent
intent
use
biolog
agent
caus
diseas
simul
natur
occur
outbreak
may
unusu
characterist
cdc
issu
recommend
complet
public
health
respons
biolog
attack
two
import
compon
respons
plan
includ
rapid
diagnosi
character
biolog
agent
pathologist
use
newer
diagnost
techniqu
immunohistochemistri
situ
hybrid
pcr
direct
impact
rapid
detect
control
emerg
infecti
diseas
natur
intent
caus
immunohistochemistri
provid
simpl
safe
sensit
specif
method
rapid
detect
either
time
investig
retrospect
biolog
threat
facilit
rapid
implement
effect
public
health
respons
immunohistochem
stain
bacillu
anthraci
monoclon
antibodi
cell
wall
capsul
antigen
success
use
identif
bioterrorismrel
anthrax
case
import
step
earli
diagnosi
treatment
case
gram
stain
cultur
isol
b
anthraci
usual
method
diagnos
anthrax
nevertheless
previou
antibiot
treatment
affect
cultur
yield
gram
stain
identif
bacteria
immunohistochemistri
demonstr
high
sensit
specif
detect
b
anthraci
skin
biopsi
pleural
biopsi
transbronchi
biopsi
pleural
fluid
fig
addit
immunostain
use
determin
rout
entri
bacteria
identif
mode
spread
diseas
tularemia
immunohistochem
stain
also
valuabl
rapid
identif
francisella
tularensi
formalinfix
tissu
section
tularemia
variabl
clinic
patholog
present
simul
infecti
diseas
anthrax
plagu
catscratch
diseas
lymphogranuloma
venereum
moreov
microorgan
difficult
demonstr
tissu
section
even
gram
stain
silver
stain
method
mous
monoclon
antibodi
lipopolysaccharid
f
tularensi
use
demonstr
intact
bacteria
granular
bacteri
antigen
lung
spleen
lymph
node
liver
high
sensit
specif
fig
plagu
mous
monoclon
antibodi
direct
fraction
antigen
yersinia
pesti
use
detect
intracellular
extracellular
bacteria
dermal
blood
vessel
lung
lymph
node
spleen
liver
fig
techniqu
potenti
use
rapid
diagnosi
plagu
formalinfix
skin
biopsi
addit
immunohistochemistri
may
allow
distinct
primari
secondari
pneumon
plagu
identifi
pesti
differ
lung
locat
ie
alveolar
versu
interstiti
immunohistochem
method
use
polyclon
monoclon
antibodi
appli
identif
sever
potenti
biolog
terror
agent
includ
antibodi
caus
agent
brucellosi
q
fever
viral
encephalitid
eastern
equin
enceph
fig
